Generation Bio Co.

27.20-1.44-5.03%Vol 690.63K1Y Perf 11.06%
Apr 9th, 2021 16:00 DELAYED
BID27.14 ASK27.20
Open28.94 Previous Close28.64
Pre-Market- After-Market-
 - -  - -%
Target Price
42.25 
Analyst Rating
— — 0.00
Potential %
55.33 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap1.53B 
Earnings Rating
Price Range Ratio 52W %
26.34 
Earnings Date
23rd Mar 2021

Today's Price Range

27.1029.07

52W Range

17.0055.72

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-7.42%
1 Month
-22.95%
3 Months
-2.61%
6 Months
-3.37%
1 Year
11.06%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
GBIO27.20-1.4400-5.03
AAPL132.992.63002.02
GOOG2 285.8820.44000.90
MSFT255.852.60001.03
XOM55.87-0.1300-0.23
WFC40.500.47001.17
JNJ161.25-1.7200-1.06
FB312.46-0.5600-0.18
GE13.600.15001.12
JPM156.281.16000.75
Earnings HistoryEstimateReportedSurprise %
Q04 2020-0.52-0.53-1.92
Q03 2020-0.45-0.46-2.22
Q02 2020-0.60-1.50-150.00
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-0.51
Estimates Count4
EPS Growth Next 5 Years %-
Volume Overview
Volume690.63K
Shares Outstanding56.43M
Trades Count5.70K
Dollar Volume18.59M
Avg. Volume695.96K
Avg. Weekly Volume460.46K
Avg. Monthly Volume692.05K
Avg. Quarterly Volume588.82K

Generation Bio Co. (NASDAQ: GBIO) stock closed at 27.2 per share at the end of the most recent trading day (a -5.03% change compared to the prior day closing price) with a volume of 690.64K shares and market capitalization of 1.53B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 85 people. Generation Bio Co. CEO is Geoffrey McDonough.

The one-year performance of Generation Bio Co. stock is 11.06%, while year-to-date (YTD) performance is -4.06%. GBIO stock has a five-year performance of %. Its 52-week range is between 17 and 55.72, which gives GBIO stock a 52-week price range ratio of 26.34%

Generation Bio Co. currently has a PE ratio of -10.20, a price-to-book (PB) ratio of 5.99, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -47.89%, a ROC of -25.25% and a ROE of -95.06%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Generation Bio Co., there were 0 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $-0.51 for the next earnings report. Generation Bio Co.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Generation Bio Co. is (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for Generation Bio Co. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Generation Bio Co. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Generation Bio Co. has a Sell technical analysis rating based on Technical Indicators (ADX : 14.11, ATR14 : 4.14, CCI20 : -19.18, Chaikin Money Flow : -0.04, MACD : 0.81, Money Flow Index : 56.55, ROC : -5.51, RSI : 51.45, STOCH (14,3) : 46.97, STOCH RSI : 0.34, UO : 48.58, Williams %R : -53.03), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Generation Bio Co. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Summary Rating---

Generation Bio Co.

Generation Bio Co is a genetics medicine company which is focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina related diseases.

CEO: Geoffrey McDonough

Telephone: +1 617 655-7500

Address: 301 Binney Street, Cambridge 02142, MA, US

Number of employees: 85

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

60%40%

Bearish Bullish

53%47%

Bearish Bullish

58%42%

News

Stocktwits